Samsung brings in the lawyers for biosimilars push

SEOUL (Reuters) - Samsung Bioepis Co Ltd, which aims to become a force in the fledgling biosimilar drugs industry, has filed a lawsuit against the originator of the world's best-selling drug, to stop it blocking the launch of its own version.

http://ift.tt/1RW5nhu

from Reuters: Health News
via animenewspro